Evidence map›Paper›PMID 25589651›Full record

ArticleJournal of virology2015

Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.

Christoph T Berger, Anuska Llano, Jonathan M Carlson, Zabrina L Brumme, Mark A Brockman, Samandhy Cedeño, P Richard Harrigan, Daniel E Kaufmann, David Heckerman, Andreas Meyerhans and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Creation of the HIV-1 antisense geneMicrobiology spectrum · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Christoph T BergerRagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA Translational Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-1730-8824
Anuska LlanoIrsiCaixa AIDS Research Institute-HIVACAT, Hospital Germans Trias I Pujol, Badalona, Spain.
Jonathan M CarlsonMicrosoft Research, Seattle, Washington, USA.
Zabrina L BrummeSimon Fraser University, Burnaby, BC, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Mark A BrockmanSimon Fraser University, Burnaby, BC, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Samandhy CedeñoIrsiCaixa AIDS Research Institute-HIVACAT, Hospital Germans Trias I Pujol, Badalona, Spain.
P Richard HarriganBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
Daniel E KaufmannRagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA University of Montreal Hospital Research Center (CRCHUM), Montreal, QC, Canada.
David HeckermanMicrosoft Research, Seattle, Washington, USA.
Andreas MeyerhansInfection Biology Group, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain.
Christian BranderIrsiCaixa AIDS Research Institute-HIVACAT, Hospital Germans Trias I Pujol, Badalona, Spain Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona, Spain University of Vic and Central University of Catalonia, Vic, Catalonia, Spain Autonomous University of Barcelona, Barcelona, Catalonia, Spain cbrander@irsicaixa.es.
IrsiCaixa · ESMicrosoft (United States) · USRagon Institute of MGH, MIT and Harvard · USSimon Fraser University · CAAIDS Vancouver · CAInstitució Catalana de Recerca i Estudis Avançats · ESUniversitat de Vic - Universitat Central de Catalunya · ES

Funding

Promiscuous presentation of HLA class I restricted, HIV derived CTL epitopesR01AI067077 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KAUFMANN, DANIEL E · 2005 to 2009
$1.9M
Canadian Institutes of Health ResearchNIAID NIH HHS R01 AI067077PHS HHS R01 067077
6 · The paper itself

Abstract

Cytotoxic-T lymphocyte (CTL) responses to epitopes in alternative HIV reading frames have been reported. However, the extent of CTL responses to putative proteins encoded in antisense reading frames is unknown. Using sequence alignments and computational approaches, we here predict five potential antisense HIV proteins and characterize common CTL responses against them. Results suggest that antisense-derived sequences are commonly transcribed and translated and could encode functional proteins that contain important targets of anti-HIV cellular immunity.

Indexed as

HIV-1HIV AntigensHumansOpen Reading FramesReading FramesRNA, AntisenseT-Lymphocytes, CytotoxicHIV AntigensRNA, Antisense

Identifiers

PMID25589651
PMCPMC4403399
OpenAlexW2027918264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.